ESR1 and breast cancer: In breast cancer studies, a miR-206-binding site has been found within the 3′-untranslated regions (3′-UTR) of ER-α, and this microRNA is present at higher levels in MDA-MB-231 cells (ER-α negative) than in MCF-7 cells (ER-α positive) [24, 25].